- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: daytime dosing of mirabegron
Total 1712 results
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Chinese University of Hong KongActive, not recruiting
-
University of PennsylvaniaAmerican Heart AssociationCompletedCoronary Disease | Cardiac Arrest | Cardiovascular Risk FactorsUnited States
-
AHS Cancer Control AlbertaActive, not recruiting
-
Heinrich-Heine University, DuesseldorfUnknownSleep-related Respiratory DisorderGermany
-
The Affiliated Ganzhou Hospital of Nanchang UniversityActive, not recruiting
-
Genuine Research Center, EgyptMulti-Apex PharmaCompleted
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteCompletedCoronary Disease | Cardiac Arrest | Cardiovascular Risk FactorsUnited States
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Thomas Jefferson UniversityAstellas Pharma IncTerminatedAchalasiaUnited States
-
Massachusetts General HospitalRecruitingSleep | Glucose Intolerance | Feeding PatternsUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability | Pharmacokinetics of MirabegronNetherlands
-
Cedars-Sinai Medical CenterRecruitingSyncope | Postural Orthostatic Tachycardia Syndrome | Chronic Orthostatic IntoleranceUnited States
-
University of PennsylvaniaCompletedCoronary Disease | Cardiac Arrest | Cardiovascular Risk FactorsUnited States
-
Peking Union Medical College HospitalNot yet recruiting
-
Far Eastern Memorial HospitalRecruitingFemale Patients With Overactive Bladder SyndromeTaiwan
-
Astellas Pharma China, Inc.CompletedPharmacokinetics of Mirabegron | Food Effect | Healthy Chinese SubjectsChina
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
Astellas Pharma Europe B.V.Completed
-
Columbia UniversityUniversity of Copenhagen; HIASActive, not recruitingStress | Psychological Distress | Mental Health Wellness 1 | Coping SkillsEcuador, Panama
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Samsung Medical CenterCompleted
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
Seoul National University HospitalUnknown
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Taipei Veterans General Hospital, TaiwanRecruitingOveractive Bladder SyndromeTaiwan
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingDiabetes Mellitus, Type 2
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
Astellas Pharma China, Inc.CompletedUrge Incontinence | Overactive Bladder (OAB)China
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Buddhist Tzu Chi General HospitalCompletedUrinary Incontinence | Overactive Bladder Syndrome
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy Volunteer | Pharmacokinetics of YM178Taiwan
-
Astellas Pharma IncCompletedOveractive Bladder | PharmacokineticsFrance
-
HealthPartners InstituteCompletedOveractive Bladder | Parkinson Disease | Impaired CognitionUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
National Taiwan University HospitalCompletedRecurrence of Overactive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompleted
-
University of Alabama at BirminghamCompletedOveractive BladderUnited States
-
Tianjin Medical University General HospitalRecruiting
-
Astellas Pharma IncCompleted
-
Catalan Institute of HealthCompletedOveractive Bladder Syndrome
-
Achros Health Technologies CorporationUnknownCritical Illness | Mechanical VentilationHungary
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
University Hospitals Cleveland Medical CenterWithdrawnOveractive BladderUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland